Search
for
Sort by
Research 151–180 of 432
- Hypersensitivity Reactions to Anticoagulant Drugs
- Skin manifestations among<i>GATA2</i>-deficient patients
- Reversible Alopecia Universalis During Treatment with PEG-Interferon and Ribavirin for Chronic Hepatitis C
- Psychodermatology
- Recurrence of Pemphigus Vulgaris Associated With Interleukin 2 Therapy
- Nutrition and the deleterious side effects of nutritional supplements
- INTERFERONS IN DERMATOLOGY
- The Influence of Various Parameters on the Success of Sensor-Controlled Scalp Cooling in Preventing Chemotherapy-Induced Alopecia
- Teriflunomide in multiple sclerosis: an update
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- Limited stage small cell lung cancer
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- New treatments for rheumatoid arthritis
- Retinoids for Chemoprophylaxis of Nonmelanoma Skin Cancer
- Congenital atrichia and hypotrichosis
- Immunomodulators in the treatment of cutaneous lymphoma
- Multiple minute digitate hyperkeratosis
- Telogen Effluvium Associated with Albendazole Therapy
- Skin eruptions specific to pregnancy: an overview
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Real-World Evidence for Baricitinib in the Treatment of Atopic Dermatitis and Alopecia Areata: Systematic Literature Review 2020–2023
- Janus kinase inhibitors for alopecia areata: a review of clinical data
- Safety of oral JAK inhibitors in treating alopecia areata: a systematic review and network meta-analysis
- Off-label use of biologics and janus kinase (JAK) inhibitors for scarring alopecias: a narrative review
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- A Case Report of Male Systemic Lupus Erythematous with Antinuclear Antibodies-Negative: A Challenging Diagnosis
- Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women
- Cutaneous Reactions to Drugs